Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biochem Parasitol ; 112(1): 19-28, 2001 Jan 15.
Article in English | MEDLINE | ID: mdl-11166383

ABSTRACT

In this study, we describe the isolation and characterization of a new adenylyl cyclase from Trypanosoma brucei and its activation by dimerization of the catalytic domain. In agreement with the current nomenclature of trypanosomal adenylyl cyclases, this new gene is termed GRESAG4.4B. The complete ORF of the GRESAG4.4B gene encodes a protein of 1291 amino acids. Its predicted protein structure is consistent with the structure of other trypanosomal cyclases, and with the cyclases of L. donovani. GRESAG 4.4B is constitutively expressed during the life cycle of trypanosomes. GRESAG4.4B is a member of a gene family, which contains at least six members, which are all clustered on chromosome IV. The catalytic domain of GRESAG4.4B is able to dimerize spontaneously. However, these spontaneously formed, stable dimers only show minimal enzymatic activity. The addition of a leucine zipper (LZ) derived from the S. cerevisiae GCN 4 gene to the N-terminus of the catalytic domain of GRESAG4.4B strongly activated its enzymatic activity. The LZ appears to enforce a distinct conformation of the dimer, which leads to an increased enzymatic activity, and thus may mimic the effect of ligand-induced dimerization of adenylyl cyclase in vivo.


Subject(s)
Adenylyl Cyclases/genetics , Adenylyl Cyclases/metabolism , Gene Expression Regulation, Enzymologic , Trypanosoma brucei brucei/enzymology , Trypanosoma brucei brucei/genetics , Adenylyl Cyclases/chemistry , Adenylyl Cyclases/isolation & purification , Amino Acid Sequence , Animals , Catalytic Domain/genetics , Catalytic Domain/physiology , Chromosome Mapping , Dimerization , Enzyme Activation , Leucine Zippers/genetics , Leucine Zippers/physiology , Molecular Sequence Data , Recombinant Proteins/metabolism , Trypanosomiasis, African/parasitology
2.
Parasitol Today ; 16(1): 35-8, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10637587

ABSTRACT

Curative interference with signal transduction pathways is a spectacularly successful concept in many domains of modern pharmacology; indeed, the 'wonder drug' Viagra is but a humble inhibitor of a cyclic GMP (cGMP)-specific phosphodiesterase and, thus, interferes with cGMP-signaling in a strategic organ. In fact, about half of the 100 most successful drugs currently on the market act through modulating cellular signal transduction. Despite these encouraging findings, signal transduction pathways as potential drug targets in trypanosomatids have remained largely unexplored. However, what little is known indicates that adenylyl cyclases of trypanosomatids, and probably other enzymes of the cyclic nucleotide signaling pathways, are significantly different from their mammalian counterparts. Here, Christina Naula and Thomas Seebeck summarize what is known about cAMP signal transduction in trypanosomatids.


Subject(s)
Cyclic AMP/physiology , Signal Transduction/physiology , Trypanosoma brucei brucei/physiology , Trypanosoma cruzi/physiology , Adenylyl Cyclases/chemistry , Adenylyl Cyclases/physiology , Amino Acid Sequence , Animals , Chagas Disease/parasitology , Cyclic AMP-Dependent Protein Kinases/physiology , Molecular Sequence Data , Sequence Alignment , Sequence Homology, Amino Acid , Trypanosoma brucei brucei/growth & development , Trypanosoma cruzi/growth & development , Trypanosomiasis, African/parasitology , Variant Surface Glycoproteins, Trypanosoma/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...